Apr 13, 2023 · 40 min
Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
Apr 6, 2023 · 36 min253: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers
Mar 30, 2023 · 36 min252: Biotech's monkey shortage, the broken generics market, & conference cancel culture
Mar 23, 2023 · 34 min251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster
Mar 16, 2023 · 35 min250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
Mar 9, 2023 · 38 min249: Robert Califf on how drugs get approved, plus the nascent revolution in obesity
Mar 2, 2023 · 28 min248: The next CRISPR fight, cheaper insulin, & an FDA shuffle
Feb 23, 2023 · 38 min247: Vertex vs. insurers, Moderna's future, & biotech's long winter
Feb 16, 2023 · 40 min246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid
Feb 9, 2023 · 20 min245: The return of bird flu and the effects of pandemic fatigue
Feb 2, 2023 · 35 min244: Pharma blockbusters, pandemic policy, & legal chicanery
Jan 26, 2023 · 31 min243: George Scangos' retirement, annual Covid vaccines, an Alzheimer's drug rejection
Jan 19, 2023 · 32 min242: How blockbusters get made, new vaccines for RSV, and mRNA's Q score
Jan 12, 2023 · 32 min241: #JPM23 in review, the year ahead, & the merits of Miami
Jan 5, 2023 · 36 min240: #JPM23, the future of Alzheimer's, & rising Covid variants
Dec 22, 2022 · 29 min239: 2022 in review, CEO indictments, & the year ahead
Dec 15, 2022 · 36 min238: Leaky health data, ASH22, & what it takes to get booed by your peers
Dec 8, 2022 · 35 min237: The 'electric vehicles' of pharma, Illumina's boondoggle, & a Theranos sentencing
Dec 1, 2022 · 33 min236: Wither PhRMA, Alzheimer's treatment data revealed, and the first fecal microbiome drug approval
Nov 17, 2022 · 28 min235: LIVE from the STAT Summit